In patients with lung cancer, a novel tumor-infiltrating B7-H3+CD14+HLA-DR−/low subset of MDSCs is reported to induce Tregs in vitro, which is partly dependent upon IL-10 (40). This evidence concerns the gene IL10 and neoplasm.